|
Immediately
Following CHI's Sixth Annual Phage
Display Technologies conference, April 26-27 and CHI’s
Fifth Annual Recombinant Antibodies conference, April 28-29
Overview
With the phenomenal growth in the market for
monoclonal antibodies, more and more companies are pursuing widely diverse
approaches to applying monoclonal antibody technology to both drug discovery
and therapeutic applications. This conference will provide researchers with
key updates on important developments in the monoclonal antibody field,
covering generation, therapeutics, drug discovery research and in vivo
diagnostics.
Dr. Edward Greenfield, Millennium Pharmaceuticals
|
New Developments in Generating and
Improving Monoclonals |
GENOVAC Technology: A Shortcut from Genomics to
Proteomics
Humanization of Murine Antibodies by Resurfacing is a Robust Method for
Producing High-Affinity, Stable, Humanized Antibodies, and Clinical Data
Demonstrates That the Method Effectively Eliminates the Immunogenicity of
the Murine Antibody
The
Creation and Use of New E. coli Strains
Case
Study:
Variations in Immunoassay Results Using a Duel Monoclonal Antibody
Format
Capillary Electrophoresis: A Rapid Analysis Tool and an Emerging Technology
Human Antibodies in Humans: Overcoming Challenges
Taking a Discovery-Level Antibody into Production and Preclinical
Development:
A Case Study
Discovering Oncology Antibodies from Diseased Plasma
An
Antibody Specific for Coagulation Factor IX Enhances the Activity of the
Intrinsic Factor X-Activating Complex
Use
of Statistical Experimental Design Methods in Developing a
High-Concentration Liquid Formulation for a Monoclonal Antibody
The
Role of Process Simulation in the Development, Evaluation and
De-bottlenecking of Monoclonal Antibody Production Processes
CALL FOR
EXHIBITORS & SPONSORS
Showcase
your company's expertise, brand your solutions and develop revenue
opportunities with qualified decision-makers by becoming an Exhibitor or
Sponsor of Recombinant Antibodies and Monoclonal Antibodies 2004!
If you want to discuss sponsoring or exhibiting, please contact Carol
Dinerstein at 781-972-5471 or
dinerstein@healthtech.com
|
